Gerard A. Silvestri

Q: What Schools Are Affiliated With Gerard A. Silvestri

Gerard A. Silvestri is affiliated with the following schools: Medical University of South Carolina

Gerard A. Silvestri's AcademicInfluence.com Rankings

Gerard A. Silvestri

Philosophy

#8204

World Rank

#11539

Historical Rank

Logic

#5233

World Rank

#6617

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Gerard A. Silvestri's Degrees

Doctorate Medicine University of Pittsburgh
Masters Clinical Research Medical University of South Carolina

Why Is Gerard A. Silvestri Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gerard A. Silvestri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. (2013) (1125)
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). (2007) (688)
Selection criteria for lung-cancer screening. (2013) (655)
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). (2007) (612)
Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. (2003) (590)
Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. (2012) (514)
Targeting of low-dose CT screening according to the risk of lung-cancer death. (2013) (509)
Cost-effectiveness of CT screening in the National Lung Screening Trial. (2014) (461)
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews (1998) (374)
One hundred years of lung cancer. (2005) (355)
The noninvasive staging of non-small cell lung cancer: the guidelines. (2003) (301)
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. (2002) (299)
Technical Aspects of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report. (2016) (290)
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. (2003) (289)
Pulmonary complications after esophagectomy. (2002) (264)
Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. (2007) (264)
Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer. (1996) (255)
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts (2014) (244)
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report (2018) (222)
Specialists achieve better outcomes than generalists for lung cancer surgery. (1998) (213)
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. (2015) (212)
American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. (2012) (211)
Importance of faith on medical decisions regarding cancer care. (2003) (210)
American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. (2011) (203)
Racial Differences Pertaining to a Belief about Lung Cancer Surgery: Results of a Multicenter Survey (2003) (201)
Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. (2001) (193)
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. (2015) (169)
Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts (2007) (161)
Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. (2004) (157)
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. (2016) (144)
Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. (2008) (139)
The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. (1994) (136)
Invasive staging: The guidelines (2003) (135)
American College of Chest Physicians and American Association for Bronchology Consensus Statement (2005) (132)
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). (2007) (130)
Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy. (1999) (123)
A prospective multicenter study of competency metrics and educational interventions in the learning of bronchoscopy among new pulmonary fellows. (2010) (122)
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. (2005) (121)
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules (2007) (118)
Pulmonary complications of radiation therapy. (2004) (117)
Management of Pulmonary Nodules by Community Pulmonologists (2015) (114)
A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. (2007) (114)
Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy (2019) (110)
A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. (2009) (110)
Lung cancer screening. (2015) (99)
Lung cancer: Progress in diagnosis, staging and therapy (2010) (99)
Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. (2005) (98)
Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. (2015) (95)
Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules (2015) (95)
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. (2016) (95)
The effect of respiratory motion on pulmonary nodule location during electromagnetic navigation bronchoscopy. (2015) (94)
Robotic Bronchoscopy for Peripheral Pulmonary Lesions (2020) (89)
Pulmonary nodule volume: effects of reconstruction parameters on automated measurements--a phantom study. (2008) (88)
Endobronchial ultrasound for the diagnosis and staging of lung cancer. (2009) (87)
Increasing Physical Activity and Exercise in Lung Cancer: Reviewing Safety, Benefits, and Application (2015) (86)
Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules (2018) (84)
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. (2011) (84)
Intensive care decision making in the seriously ill and elderly* (2004) (84)
Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules (2018) (84)
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. (2014) (81)
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement (2017) (78)
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. (2008) (77)
Adult Bronchoscopy Training: Current State and Suggestions for the Future: CHEST Expert Panel Report. (2015) (75)
Racial and Ethnic Disparities in Early‐Stage Lung Cancer Survival (2017) (74)
Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial (2018) (72)
Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. (1995) (72)
Interventional Pulmonology Fellowship Accreditation Standards: Executive Summary of the Multisociety Interventional Pulmonology Fellowship Accreditation Committee (2017) (71)
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic (2020) (68)
Bronchoscopy for the diagnosis and staging of lung cancer. (2008) (67)
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation (2017) (67)
Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy (2015) (65)
Lung Cancer Screening Practices of Primary Care Physicians: Results From a National Survey (2012) (62)
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report (2020) (62)
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement (2018) (59)
State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States (2020) (57)
Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood (2003) (56)
Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. (2004) (55)
Screening and early detection efforts in lung cancer (2015) (54)
Diagnosis and staging of lung cancer. (2000) (54)
Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. (2014) (53)
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. (2003) (52)
Nurses' identification of important yet under-utilized end-of-life care skills for patients with life-limiting or terminal illnesses. (2010) (52)
U.S. primary care physicians' lung cancer screening beliefs and recommendations. (2010) (50)
Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. (2013) (49)
Mediastinal staging of non-small-cell lung cancer. (2001) (48)
Attitudes and beliefs toward lung cancer screening among US Veterans. (2013) (48)
Learning experience of linear endobronchial ultrasound among pulmonary trainees. (2014) (48)
Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease (2017) (48)
American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection. (2005) (47)
The changing epidemiology of lung cancer with a focus on screening (2009) (46)
Successful real-time endobronchial ultrasound-guided transbronchial needle aspiration of a hilar lung mass obtained by traversing the pulmonary artery. (2006) (44)
Lung cancer. Invasive staging: the guidelines. (2003) (42)
Screening for Lung Cancer: It Works, but Does It Really Work? (2011) (40)
Assessing the Correlation Between Physical Activity and Quality of Life in Advanced Lung Cancer (2016) (40)
The Master Settlement Agreement and its impact on tobacco use 10 years later: lessons for physicians about health policy making. (2010) (40)
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. (2021) (40)
Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. The Canadian Lung Oncology Group. (2001) (39)
Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. (2009) (38)
Measuring the quality of end-of-life care. (2010) (37)
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial (2018) (36)
Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer. (2016) (35)
Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. (1992) (35)
Barriers to hospice enrollment among lung cancer patients: A survey of family members and physicians (2008) (34)
Current Status of Tobacco Policy and Control (2012) (34)
Invited commentary: the etiology of lung cancer in men compared with women. (2013) (34)
Glutathione S-transferase M1 polymorphism and the risk of lung cancer. (2003) (33)
Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. (2019) (33)
Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. (2013) (32)
Usefulness of transbronchial needle aspiration in evaluating patients with lung cancer (2005) (32)
The treatment of advanced non-small cell lung cancer (2005) (32)
Training for linear endobronchial ultrasound among US pulmonary/critical care fellowships: a survey of fellowship directors. (2013) (32)
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. (2012) (31)
Estimating the Effect of Individual Time Preferences on the Use of Disease Screening (2010) (31)
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. (2014) (31)
Understanding the economic impact of introducing a new procedure: calculating downstream revenue of endobronchial ultrasound with transbronchial needle aspiration as a model. (2012) (31)
Accuracy of a Robotic Endoscopic System in Cadaver Models with Simulated Tumor Targets: ACCESS Study (2019) (31)
Physician Preferences for Management of Patients with Stage IIIA NSCLC: Impact of Bulk of Nodal Disease on Therapy Selection (2012) (31)
Combined endoscopic and open approach to the removal of expandable metallic tracheal stents. (2007) (30)
Does entrained breathing improve the economy of rowing? (1994) (30)
Silicone Stents versus Metal Stents for Management of Benign Tracheobronchial Disease Pro: Metal Stents (2000) (29)
Latest advances in advanced diagnostic and therapeutic pulmonary procedures. (2012) (28)
The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. (1992) (27)
CT screening for lung cancer: is smaller better? (2002) (27)
Lung Cancer Screening Rates During the COVID-19 Pandemic (2021) (27)
An evaluation of diagnostic yield from Bronchoscopy: the impact of clinical/radiographic factors, procedure type and degree of suspicion for cancer. (2020) (26)
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. (2003) (26)
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement (2017) (26)
A decade of advances in treatment of early-stage lung cancer. (2011) (26)
One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer. (2003) (25)
Feasibility and safety of bronchoscopic transparenchymal nodule access in canines: a new real-time image-guided approach to lung lesions. (2014) (25)
Evaluation of dyspnea in the elderly patient. (1993) (24)
Caring for the dying patient with lung cancer. (2002) (23)
A review of clinical practice guidelines for lung cancer. (2013) (23)
An evaluation of procedural training in Canadian respirology fellowship programs: program directors' and fellows' perspectives. (2009) (22)
High yield of bronchoscopic transparenchymal nodule access real-time image-guided sampling in a novel model of small pulmonary nodules in canines. (2015) (22)
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. (2020) (22)
Involved‐field radiotherapy with concurrent chemotherapy for limited‐stage small‐cell lung cancer: Disease control, patterns of failure and survival (2010) (21)
Utilizing Endobronchial Ultrasound With Fine-Needle Aspiration to Obtain Tissue for Molecular Analysis: A Single-Center Experience (2011) (21)
Screening for lung cancer. (2008) (21)
Boys (and girls) and their toys: a look at new technologies in the bronchoscopy suite. (2007) (20)
Carcinoma of the bronchus 60 years later (2006) (20)
Safety and diagnostic performance of pulmonologists performing electromagnetic guided percutaneous lung biopsy (SPiNperc) (2019) (19)
In‐person and Telephonic Shared Decision‐making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality (2019) (18)
Fospropofol Disodium for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy (2008) (18)
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. (2009) (17)
A Patient-Centered Activity Regimen Improves Participation in Physical Activity Interventions in Advanced-Stage Lung Cancer (2018) (17)
Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound‐guided transbronchial fine‐needle aspiration of mediastinal lymph nodes (2015) (16)
The Evolution of Bronchoscopy Training (2008) (16)
Master Settlement Agreement (MSA) Spending and Tobacco Control Efforts (2014) (16)
Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial. (2019) (16)
Factors that influence physician decision making for indeterminate pulmonary nodules. (2013) (16)
Study Design and Rationale: A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic Navigational Approaches for the Biopsy of Peripheral Pulmonary Nodules (ALL IN ONE Trial). (2018) (15)
Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement. (2019) (15)
Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable (2019) (15)
New testing for lung cancer screening. (2012) (15)
Construct Validity of the Simbionix Bronch Mentor Simulator for Essential Bronchoscopic Skills (2013) (14)
Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. (2018) (14)
Low-dose CT for lung cancer screening. (2018) (14)
Variation in Experts’ Beliefs about Lung Cancer Growth, Progression, and Prognosis (2008) (14)
Influence of Nodule Detection Software on Radiologists' Confidence in Identifying Pulmonary Nodules With Computed Tomography (2011) (13)
Screening for lung cancer in a high-risk group: but I still haven't found what I’m looking for… (2006) (13)
Lung and bronchus cancer disparities in South Carolina: epidemiology and strategies for prevention. (2006) (13)
Pulmonary blastoma: a rare lung malignancy. (1996) (13)
ADHERENCE TO ANNUAL LUNG CANCER SCREENING WITHIN THE VETERANS HEALTH ADMINISTRATION LUNG CANCER SCREENING DEMONSTRATION PROJECT (2018) (13)
EGFR mutations in malignant pleural effusions from lung cancer (2013) (12)
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository (2016) (12)
An Update on Sedation and Analgesia During Flexible Bronchoscopy (2007) (12)
Strange Bedfellows: The Interaction between COPD and Lung Cancer in the Context of Lung Cancer Screening (2020) (11)
Biomarkers in the selection of maintenance therapy in non-small cell lung cancer. (2012) (11)
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. (2016) (11)
Palliative Care in Lung Cancer: A Review (2016) (11)
Lung cancer staging (2002) (11)
Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2 Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. (2020) (11)
Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation. (2011) (11)
Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of Respiration (2018) (11)
Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. (2019) (10)
A seismic shift in staging. (2007) (10)
First-in-Human Use of a Hybrid Real-Time Ultrasound-Guided Fine-Needle Acquisition System for Peripheral Pulmonary Lesions: A Multicenter Pilot Study (2019) (9)
Evaluation and treatment of high-risk patients with early-stage lung cancer. (2011) (9)
“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study” (2021) (9)
Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States (2021) (9)
The mounting evidence for endobronchial ultrasound. (2009) (9)
Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. (2017) (8)
Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists (2021) (8)
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic (2020) (8)
Bronchoscopy for the solitary pulmonary nodule: friend or foe? (2012) (8)
Imaging of Lung Cancer (2006) (7)
Lung Cancer Screening (2008) (7)
Rest in Peace: The Decline in Training and Use of the Closed Pleural Biopsy (2005) (7)
Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017 to 2019. (2021) (7)
An institution-wide faculty mentoring program at an academic health center with 6-year prospective outcome data (2019) (7)
Conformal High Dose External Radiation Therapy, 80.5 Gy, Alone for Medically Inoperable Non-small Cell Lung Cancer: A Retrospective Analysis (2006) (7)
Peripheral Bronchoscopy Training Using a Human Cadaveric Model and Simulated Tumor Targets (2016) (7)
Fellows' Perspective of Their Training in Interventional Pulmonary Procedures (2005) (7)
MULTICENTER, PROSPECTIVE PILOT AND FEASIBILITY STUDY OF ROBOTIC-ASSISTED BRONCHOSCOPY FOR PERIPHERAL PULMONARY LESIONS (2019) (7)
Characteristics of Persons Screened for Lung Cancer in the United States (2022) (6)
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer. (2020) (6)
Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina. (2007) (6)
A 79-year-old woman with a right paratracheal mass. (2009) (6)
Correlation of Vital Signs and Depth of Sedation by Modified Observer's Assessment of Alertness and Sedation (MOAA/S) Scale in Bronchoscopy. (2021) (6)
You just can't call it lung cancer anymore. (2011) (6)
Diagnostic Approach to the Solitary Pulmonary Nodule (2013) (6)
Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. (2017) (6)
Fire and Ice: Laser Bronchoscopy, Electrocautery and Cryotherapy (2008) (6)
Chemotherapy for advanced lung cancer: is the glass half full or half empty? (2004) (5)
ASSESSMENT OF PULMONARY FELLOWS ACQUISITION OF BRONCHOSCOPY SKILLS (2007) (5)
Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. (2020) (5)
Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. (2013) (5)
Variation In Training for Interventional Pulmonary Procedures Among U.S. Pulmonary/Critical Care Fellowships (2004) (5)
Predicted impact of attaining smoking reduction goals on mortality. (2001) (4)
A tale of two cities: comparing lung cancer outcomes in Teesside, UK and Varese, Italy (2006) (4)
Development and Testing of Multivariate Statistical Model To Predict Malignancy of Small (<1.5cm) Pulmonary Nodules. (2009) (4)
Multidisciplinary management of lung cancer. (2004) (4)
POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. (2015) (4)
THE MULTI-STATE BRONCHOSCOPY EDUCATION PROJECT: ACQUISITION OF COGNITIVE SKILLS (2007) (4)
Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? (2015) (4)
Cost effectiveness of endoscopic ultrasonography with fine needle aspiration V. Mediastinoscopy in the staging of patients with lung cancer (1996) (4)
Bronchial Thermoplasty in Severe Asthmatics At 5 Years: The PAS2 Study. (2021) (4)
Smoking and pulmonary and cardiovascular diseases: Preface (2000) (4)
Combined Navigational Transthoracic Needle Biopsy and Bronchoscopy for the Diagnosis of Peripheral Pulmonary Nodules: A Prospective Human Study (2015) (4)
53 – Clinical Aspects of Lung Cancer (2016) (4)
Predicting The Probability Of Malignancy In Patients With Pulmonary Nodules: Comparison Of Clinical Judgment With Two Validated Models (2012) (4)
Looking to our past to find the way forward for the american association of bronchology and interventional pulmonology. (2010) (4)
The Global Impact of Respiratory Disease-Third Edition (2021) (4)
The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of symptomatic disease. (2003) (3)
Comparison of the Thin Convex Probe Endobronchial Ultrasound Bronchoscope to Standard EBUS and Flexible Bronchoscope: A Cadaveric Study (2016) (3)
NARROW BAND IMAGING COMPARED TO WHITE LIGHT BRONCHOSCOPY FOR EVALUATION OF NORMAL, PRE-MALIGNANT AND MALIGNANT AIRWAYS DISEASE (2006) (3)
FOSPROPOFOL DISODIUM IS EFFECTIVE AND SAFE FOR SEDATION IN PATIENTS UNDERGOING FLEXIBLE BRONCHOSCOPY: RESULTS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOSE-CONTROLLED TRIAL (2007) (3)
What's in a Number? When It Comes to Pulmonary Nodules, It's All About the Number. (2015) (3)
Impact of Tobacco Dependence in Risk Prediction Models for Lung Cancer Diagnoses and Deaths (2019) (3)
Cigarette smoking and the risk of dying from tobacco-related malignancies by race. (2011) (3)
Cancer Outcomes Among Medicare Beneficiaries And Their Younger Uninsured Counterparts. (2021) (3)
Staging strategies for patients with newly diagnosed bronchogenic carcinoma : The importance of the clinical evaluation (1996) (3)
Could Cryo-Biopsies Lead Bronchoscopy Into the Ice Age? (2016) (3)
Tobacco Treatment Specialist Training for Lung Cancer Screening Providers. (2021) (3)
An up to date look at lung cancer screening (2010) (3)
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report - Executive Summary. (2021) (3)
Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality (2018) (3)
ROBOTIC-ASSISTED BRONCHOSCOPIC BIOPSY OF PERIPHERAL PULMONARY LESIONS IN A CADAVERIC MODEL WITH SIMULATED TUMOR TARGETS (2018) (3)
Tissue verification of stage I sarcoidosis: the question is if, not how. (2008) (3)
Setting the Stage for Success in Lung Cancer: The Importance of Remembering Your (Guide)Lines. (2019) (2)
Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. (2019) (2)
The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation Model (2022) (2)
CT screening for lung cancer. (2007) (2)
The Latest Generation in Flexible Bronchoscopes: A Description and Evaluation (2013) (2)
Competencies in Pulmonary Procedures (2004) (2)
Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters (2022) (2)
Guided bronchoscopy for the evaluation of pulmonary lesions: An updated meta-analysis. (2023) (2)
UPDATED META-ANALYSIS OF GUIDED BRONCHOSCOPY FOR THE EVALUATION OF PULMONARY LESIONS (2019) (2)
Correlation Between Vital Signs and Depth of Sedation Determined by Modified Observer's Assessment of Alertness and Sedation Score (2017) (2)
Safely and Effectively Evaluating CT Detected Lung Lesions: Much Work to be Done. (2019) (2)
Computed Tomography Screening for Lung Cancer (2013) (2)
Deciding timing and technique for tracheostomy. (1993) (2)
Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections (2018) (2)
Smoking Trends and Lung Cancer Mortality: The Good, the Bad, and the Ugly (2018) (2)
Lung Cancer (Fossella FV, Komaki R, Putnam JB Jr, editors) (2004) (2)
Bronchoscopic trans-parenchymal nodule access (BTPNA) – A new real-time image-guided approach to accessing solitary pulmonary nodules (SPNs) - First in human data (2014) (2)
Incorporating baseline lung function in lung cancer screening: Does a "lung health check" help predict outcomes? (2020) (2)
Lumps, bumps, spots, and shadows: the scary world of the solitary pulmonary nodule. (2013) (2)
Invasive Staging of Non-small Cell Lung Cancer (2013) (2)
A Case of Primary Tracheal Paraganglioma (2003) (2)
Evaluation of a Steerable Tube Thoracostomy System Compatible with a Flexible Bronchoscope (2016) (2)
Reducing Disparities in Lung Cancer Screening: It's Not so Black and White. (2021) (2)
Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017 (2019) (2)
Denture Misadventure: An Unusual Cause of Hemoptysis (2009) (2)
Conformal high-dose external radiation therapy (CHERT) alone for medically inoperable non-small cell lung cancer (MILC). (2004) (1)
Providing Palliative Care for Patients With Lung Cancer (2017) (1)
Factors Associated With Lung Cancer Screening Adherence Among Patients With Negative Baseline CT Results in a Community Health Care Setting. (2021) (1)
The Diagnostic Dilemma in Suspected Ventilator- Associated Pneumonia (2017) (1)
2 Critically Assessing the Literature: Understanding Error and Bias (2011) (1)
Physician concern about delaying lung cancer treatment while awaiting biomarker testing: Results of a survey of U.S. oncologists. (2021) (1)
Variation in the efficacy of low-dose computed tomographic lung screening based on risk of lung cancer mortality in the National Lung Screening Trial. (2013) (1)
An institution-wide faculty mentoring program at an academic health center with 6-year prospective outcome data – ADDENDUM (2020) (1)
SARCOID-LIKE REACTION TO IMMUNOTHERAPY MIMICS PROGRESSIVE MALIGNANCY ON IMAGING (2020) (1)
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study (2022) (1)
Effects of Interventional Procedures on Quality of Life and Pulmonary Function (2004) (1)
Prospective Validation of a Bronchial Genomic Classifier for Lung Cancer in Patients Undergoing Diagnostic Bronchoscopy: The AEGIS Trials (2015) (1)
Assessing the Imaging Literature: Understanding Error and Bias (2013) (1)
Assessing the Benefits and Use of Gain-Framed Text Messaging to Improve Physical Activity in Advanced Stage Lung Cancer (2017) (1)
Quality-of-life improvement and cost-effectiveness of interventional pulmonary procedures. (2013) (1)
Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer (1997) (1)
Lung cancer screening with low-dose CT: benefits and potential risks (2012) (1)
Lung Cancer Risk (PLCOm2012) and Pre-Existing Respiratory Morbidity in a Post-Hoc Analysis of the National Lung Screening Trial (NLST-ACRIN, N=10,054) (2019) (1)
Lung Cancer Risk (PLCOm2012) and Surgical Rates for Lung Cancer in a Post-Hoc Analysis of the National Lung Screening Trial (NLST-ACRIN, N=10,054) (2019) (1)
Palliation for the dying patient with lung cancer. (2000) (1)
Comparison of the Thin Convex Probe Endobronchial Ultrasound Bronchoscope to Standard Endobronchial Ultrasound and Flexible Bronchoscope—A Cadaveric Study (2017) (1)
Performance of Risk factor-based Guidelines and Model-based Chest CT Lung Cancer Screening in World Trade Center Exposed Fire Department Rescue/Recovery Workers. (2020) (1)
Competencies in pulmonary procedures. Authors' reply (2004) (1)
The Epidemiology of Lung Cancer (2004) (1)
Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both? (2019) (1)
P1.02-03 The Role of Lung Cancer Advocacy Organizations in Biomarker Testing (2018) (1)
Pretreatment Invasive Nodal Staging in Lung Cancer: Knowledge, Attitudes, and Beliefs among Academic and Community Physicians (2021) (1)
Preoperative Evaluation for Lung Cancer Resection (2013) (1)
Pulmonary Lung Cancer Subspecialty Training. (2015) (1)
Correlating Depth of Sedation with Vital Signs and Adverse Events in Bronchoscopy (2020) (1)
PHYSICIAN ATTITUDES TOWARDS LUNG CANCER SCREENING (2008) (1)
Lung Cancer Screening: Adjuncts and Alternatives to Low-Dose CT Scans (2013) (1)
Outcomes from more than a million persons screened for lung cancer with low-dose computed tomography. (2023) (1)
Safety and Feasibility of a Sheath Cryoprobe for Bronchoscopic Transbronchial Biopsy: The FROSTBITE Trial (2022) (1)
Flexible bronchoscopy without sedation: is less or none more when it comes to sedation? (2010) (1)
A Multicenter, Community-Based Chart Review of the Evaluation and Management of Lung Nodules by Pulmonologists (2013) (1)
Case studies in the diagnosis and staging of non-small cell lung cancer. (2000) (1)
Involved-Field Radiotherapy With Concurrent Chemotherapy for Limited-Stage Small-Cell Lung Cancer: Patterns of Failure, Disease Control, and Survival (2009) (0)
Development and Validation of a Bronchoscopic Yield Prediction Model (2020) (0)
Response. (2021) (0)
PREDICTORS OF POSITIVITY IN MEDIASTINAL STAGING OF LUNG CANCER UTILIZING EBUS (2009) (0)
Lung Cancer Testing : The Past CXR / sputum screening (2017) (0)
Shared Decision Making During a Lung Cancer Screening Visit: Is it a Barrier or Does it Bring Value? (2022) (0)
User Satisfaction With Computerized Decision Support For Management Of Patients With Pulmonary Nodules (2012) (0)
Are Biopsy Negative or Nondiagnostic Lymph Nodes on EBUS Truly Negative (2013) (0)
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. (2015) (0)
23 – Diagnostic Workup for Suspected Lung Cancer Confined to the Chest (2018) (0)
Quality of End-of-Life Care Questionnaire (2016) (0)
Predictors of Smoking Cessation in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial (2022) (0)
Rebuttal From Drs Tanner and Silvestri. (2015) (0)
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide. (2023) (0)
How People Are Smoking and Quitting in the United States (2011) (0)
Filtered, Unfiltered, Light, Ultralight, Regular or Mentholated: The Effect of Cigarette Type on Lung Cancer Incidence and Mortality in the National Lung Screening Trial (2019) (0)
Demographic Differences in Those Being Screened for Lung Cancer and the Implications for Mass Screening in the U.S. (2021) (0)
CorrespondenceDisposable vs Reusable Bronchoscope Valves (2006) (0)
Assessment of an Integrated Classifier's Ability to Distinguish Benign From Malignant Nodules: Subgroup Analysis of the Oracle Registry (2023) (0)
Factors Associated with Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. (2022) (0)
Evaluation of the Patient With a Radiographic Abnormality Suspicious for Lung Cancer (2018) (0)
KNOWLEDGE AND PRACTICE PATTERNS AMONG PULMONOLOGISTS FOR MOLECULAR BIOMARKER TESTING IN ADVANCED NON-SMALL CELL LUNG CANCER (2020) (0)
Trans-parenchymal nodule access (TPNA) - Real-time image-guided approach to pulmonary nodules (2012) (0)
Response. (2021) (0)
Abstract #LB-264: Prognosis-driven drug discovery in NSCLC adenocarcinoma: High throughput screening for compounds that inhibit the epithelial-to-mesenchymal inducer Zeb1 or the metastases-inducer AGR2 (2009) (0)
6 Imaging of Lung Cancer (2011) (0)
Identification Of Molecular Markers That Indicate Prognosis In Lung Cancer Using Minimally Invasive Endobronchial Ultrasound Fine Needle Aspiration Of Lymph Nodes (2010) (0)
Pulmonary Nodule Movement During the Respiratory Cycle and the Potential Implication on Electromagnetic Navigation Bronchoscopy (2014) (0)
Creating a Flexible Continuous Procedure Distribution Model Based on Pre-Test Risk Level for Lung Cancer in Patients with Incidentally Detected Pulmonary Nodules (2018) (0)
carcinoma of the lung Endoscopic ultrasound-guided fine needle aspiration for staging patients with (2013) (0)
Multicenter, Prospective Pilot and Feasibility Study of Robotic Assisted Bronchoscopy for Peripheral Pulmonary Lesions (2019) (0)
Genetic Susceptibility to Lung Cancer and COPD in the National Lung Screening Trial: The Differing Role of Genes Conferring Risk in the Screening Setting (2019) (0)
Associations between biomarker testing and characteristics of patients with metastatic non–small cell lung cancer (mNSCLC): An analysis of CancerLinQ Discovery (CLQD) data. (2022) (0)
Mediastinal Staging in Lung Cancer The quest for a cost-effective strategy Review (2014) (0)
Patients with advanced lung cancer should share in the decision whether or not to undergo chemotherapy (2004) (0)
Improved Lung Cancer Detection in Setting of Underutilized CT Screening: Combination of a Lung Cancer Biomarker With Clinical Risk Assessment (2023) (0)
LUNG NODULE INTEGRATED CLASSIFIER BIOMARKER: FIRST DATA WITH REAL-WORLD CLINICAL USE (2020) (0)
Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy (2015) (0)
Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs (2017) (0)
The Incremental Yield of EUS Over Endobronchial US and CT for Detection of Extrathoracic Metastases in Lung Cancer (2006) (0)
Not just biology: Comparing social determinants of health in patients diagnosed with late-stage lung, breast, and colon cancer. (2022) (0)
Abstract 3305: Markers of epithelial-mesenchymal transition as indicators of prognosis in lymph node aspirates from lung cancer patients (2010) (0)
Utilizing a Computer Predictive Model to Evaluate Cost-effectiveness of Smoking Cessation Interventions and Smoking Related Illnesses (2011) (0)
Cost Efficacy of Endoscopic Ultrasound and Endobronchial Ultrasound with Fine Needle Aspiration (EUS-FNA+EBUS-FNA) Versus Mediastinoscopy for the Staging of Patients with Non Small Cell Lung Cancer (NSCLC) and Abnormal Mediastinal Lymph Nodes By Non-Invasive Imaging (2008) (0)
Abstract 5434: Machine-learning-based epigenetic detection of early-stage lung cancers using the EpiCheck liquid biopsy platform (2023) (0)
CT-Navigation Bronchoscopy For The Diagnosis Of Peripheral Pulmonary Nodules (2010) (0)
Poor Lung Cancer Screening Outcomes Was Associated With Chronic Bronchitis in a National Lung Screening Trial Subgroup (n=18,463) (2023) (0)
Endobronchial Ultrasound-Guided Biopsy of Mediastinal and Hilar Lymph Nodes: Response (2012) (0)
Rest in Peace (2005) (0)
Caring Ambassadors Lung Cancer Program (2020) (0)
Modeling the Impact on Clinical Utility, Patient Harms, And Cost of Biomarkers for the Management of Incidentally Detected Pulmonary Nodules (2018) (0)
Influences in CT Scan Lung Nodule Volumetry: Response (2014) (0)
Lung Cancer Is Just Different: Comparing the Social Determinants and Baseline Health of Patients with Lung, Colon, and Breast Cancer (2022) (0)
Bronchial Airway Gene-Expression Testing Improves the Diagnostic Yield of Bronchoscopy for Lung Cancer: Results of the AEGIS Trial (2012) (0)
Do the associations between cigarette smoking and the risk of dying from tobacco-associated malignancies differ by race? (2007) (0)
Deaths among Patients with Screen-Detected Lung Cancer (2008) (0)
DUCATION PRACTICE 69-Year-Old With Lung Mass and Mediastinal Lymphadenopathy on hest Computed Tomography (2007) (0)
MA10.06 Factors Associated with Lung Cancer Screening Adherence Among Patients with Negative Baseline Nodule Finding (2021) (0)
4588 Endoscopic ultrasound as a first-line diagnostic and staging test after ct in patients with suspected or proven lung cancer: yield in 122 consecutive patients. (2000) (0)
Lung Cancer Staging Methods: A Practical Approach (2018) (0)
Bronchoscopyin Patients Undergoing Flexible Fospropofol Disodium Injection for Moderate To Assess the Efficacy and Safety of A Phase 3, Randomized, Double-Blind Study (2009) (0)
Important Antiretroviral Drug Interactions With Benzodiazepines Used for Sedation During Bronchoscopy: Response (2012) (0)
PHYSICIAN PREFERENCES FOR MANAGEMENT OF PATIENTS WITH STAGE IIIA NON-SMALL CELL LUNG CANCER: IMPACT OF BULK OF NODAL DISEASE ON THERAPY SELECTION (2008) (0)
Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017 (2019) (0)
PD-119 Conformal high-dose external radiation therapy (CHERT) alonefor medically inoperable non-small cell lung cancer (MILC) (2005) (0)
ofHeadCTin Patients WithLung Cancer Without Clinical Evidence ofMetastases (2017) (0)
683g: EUS-FNA Detection of Micrometastases and Survival of Resected Early Stage Lung Cancer (2010) (0)
Response. (2018) (0)
Genetic Susceptibility to Lung Cancer and COPD in the National Lung Screening Trial (NLST): COPD Masks AGER Gene Susceptibility to Lung Cancer (2019) (0)
A predictive model for lung cancer screening nonadherence in a community setting health-care network (2023) (0)
Critically Assessing the Literature for Evidence-Based Imaging: Understanding Error and Bias (2018) (0)
Lung cancer: evolving concepts. (2008) (0)
Clinical Evaluation of the Thin TCP-EBUS Bronchoscopy System (Thin EBUS Pilot Study) (0)
The incremental yield of endoscopic ultrasound over endobronchial ultrasound and CT for detection of extrathoracic metastases in lung cancer (2006) (0)
Clinical Utility of a Bronchial Genomic Classifier: An Analysis of Invasive Procedure Utilization in the AEGIS Trials (2015) (0)
Multicenter, Prospective, Randomized Trial of Bronchoscopy With Ultrathin Bronchoscope and Radial Endobronchial Ultrasound With Fluoroscopy vs Standard Bronchoscopy With Fluoroscopy for Biopsy of Pulmonary Lesions (2017) (0)
A Closer Look at the Value Proposition for Endobronchial Ultrasound: Response (2012) (0)
PREDICTING THE YIELD FROM BRONCHOSCOPY: A CLOSER LOOK AT THE EFFECT OF CLINICAL/RADIOGRAPHIC FACTORS, THE TYPE OF PROCEDURE PERFORMED, AND THE PRETEST PROBABILITY OF CANCER (2018) (0)
Physician Agreement With Management Recommendations Of Computerized Decision Support For Patients With Pulmonary Nodules (2012) (0)
Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled Trial of Remimazolam: A New Ultra Short Acting Benzodiazepine for Bronchoscopy (2017) (0)
OP-JNCI180262 342..349 (2019) (0)
Gender, Competing Deaths and Outcomes from Lung Cancer Screening in the National Lung Screening Trial (NLST) (2020) (0)
High-Dose Fractionated Radiotherapy to 80 Gy for Medically Inoperable Non–Small-Cell Lung Cancer: Experience of 100 Tumors in 98 Patients (2009) (0)
Genetic Risk Score (GRS) and Lung Cancer Biology Affect Lung Cancer Screening Outcomes (2020) (0)
Influence of Nodule Detection Software (NDS) on Radiologists' Confidence in Identifying Pulmonary Nodules with CT. (2009) (0)
The Intersection of Lung Cancer Screening, Radiomics, and Artificial Intelligence: Can One Scan Really Predict the Future Development of Lung Cancer? (2023) (0)
SEDATION WITH IV REMIMAZOLAM PROVIDES RAPID ONSET, RECOVERY, AND DISCHARGE READINESS IN BRONCHOSCOPY PATIENTS: RESULTS FROM A RANDOMIZED CLINICAL TRIAL (2021) (0)
Response. (2018) (0)
Poor Lung Cancer Screening Outcomes Was Associated With Diabetes in a National Lung Screening Trial Subgroup (N=18,463) (2023) (0)
Changing recommendations for lung cancer screening: National Lung Cancer Roundtable member perspectives. (2023) (0)
Smokers Undergoing Lung Cancer Screening with Diagnosed COPD Suffer the Highest Mortality Including Similar Cardiovascular Mortality as Diabetic (2022) (0)
Why Are Women More Likely to Be Overdiagnosed With Lung Cancer? (2023) (0)
A 69-year-old with lung mass and mediastinal lymphadenopathy on chest computed tomography. (2007) (0)
Cost effectiveness of EUS-FNA plus EBUS-FNA versus mediastinoscopy for staging of non small cell lung cancer (NSCLC) with abnormal mediastinal nodes by non-invasive imaging (2009) (0)
“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study” (2021) (0)
Abstract PO-202: Cancer survival differences among Medicare beneficiaries and their younger uninsured counterparts (2020) (0)
Tremor And Dyspnea, An Uncommon Cause Of Respiratory Alkalosis (2010) (0)
Comparison of Low Dose Chest CT Screening Guidelines Within an Occupational Cohort Setting (2020) (0)
Executive summary (2019) (0)
Anesthesia for Flexible Fiberoptic Bronchoscopy (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gerard A. Silvestri?

Gerard A. Silvestri is affiliated with the following schools:

Medical University of South Carolina